How many insider trades does FilingIQ track for ACTU?

FilingIQ tracks 120 Form 4 insider transactions for ACTU (ACTUATE THERAPEUTICS, INC.), covering filings from Aug 14, 2024 onwards. 3 of those were filed in the last 90 days.

Are ACTU insiders net buyers or net sellers?

Across the full Form 4 history for ACTU, 9 transactions (8%) were open-market purchases and 20 (17%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ACTU insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ACTU in?

ACTUATE THERAPEUTICS, INC. (ACTU) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $98.09M.

ACTU insider trading

Healthcare

ACTUATE THERAPEUTICS, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

120

Last 90 days

Buys / sells

8% / 17%

Market cap

$98.09M

About ACTUATE THERAPEUTICS, INC.

Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States. The company's lead product candidate is elraglusib injection, a glycogen synthase kinase-3 inhibitor that is in Phase 2 trial to treat metastatic pancreatic ductal adenocarcinoma. It also develops elraglusib, which is in Phase 1/2 trial for the treatment of refractory pediatric malignancies, including Ewing sarcoma, as well as metastatic melanoma and colorectal cancer. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. Actuate Therapeutics, Inc. was incorporated in 2015 and is headquartered in Fort Worth, Texas.

Company website: actuatetherapeutics.com

ACTU insider activity at a glance

FilingIQ has scored 120 insider transactions for ACTU since Aug 14, 2024. The most recent filing in our index is dated Apr 1, 2026.

Across the full history, 9 open-market purchases and 20 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ACTU insider trades is 56.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ACTU trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for ACTU?: FilingIQ tracks 120 Form 4 insider transactions for ACTU (ACTUATE THERAPEUTICS, INC.), covering filings from Aug 14, 2024 onwards. 3 of those were filed in the last 90 days.
Are ACTU insiders net buyers or net sellers?: Across the full Form 4 history for ACTU, 9 transactions (8%) were open-market purchases and 20 (17%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ACTU insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ACTU in?: ACTUATE THERAPEUTICS, INC. (ACTU) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $98.09M.

Methodology & sources

Every ACTU insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.